Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Can J Urol. 2011 Aug;18(4):5819–5825.

Figure 1.

Figure 1

The effect of sunitinib and pazopanib on proliferation of human renal cell carcinoma cell lines. Cells were treated with indicated concentrations of sunitinib or pazopanib for 48 hours. Cellular proliferation was assessed using the CellTiter Blue assay.